Related Experiment Video
Updated: Jun 15, 2025

Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate
Published on: January 20, 2023
History of Risk Assessments of the Organophosphate Pesticide Chlorpyrifos at the US Environmental Protection Agency,
Christopher Sellers1, Ellen Kohl1, Marianne Sullivan1
1Christopher Sellers is with the History Department, Stony Brook University, Stony Brook, NY. Ellen Kohl is with the Department of Geography and Environmental Systems, University of Maryland-Baltimore County, Baltimore. Marianne Sullivan is with the Department of Public Health, William Patterson University of New Jersey, Wayne. Gretchen Gehrke is with the Environmental Data and Governance Initiative, Durham, NC. Jessica Varner is with the Weitzman School of Design, University of Pennsylvania, Philadelphia. Mark Chambers is with the History and Africana Studies Departments, Stony Brook University. Environmental Data and Governance Initiative is a research and advocacy nonprofit.
Abstract:
This article examines the history of risk assessments of the organophosphate pesticide chlorpyrifos at the US Environmental Protection Agency (EPA), especially after a ban on household uses in 2000. Federal funding enabled more noncorporate and place-based scientific investigations of this pesticide's harms, including child-cohort epidemiology of populations impacted through environmental injustices. This article argues, first, that their findings challenged the thin knowledge base, mostly from corporate-sponsored toxicology, that originally justified chlorpyrifos's continued use. Second, for decades, outside a court-induced interval in 2015-2016, EPA's risk assessments favored "de-placed" toxicological modes and standards of knowledge-forged in the controlled environment of experimental laboratories-while marginalizing science gathered from the actual places and people EPA is supposed to protect. Third, agency officials stuck with a quantifiable, laboratory- and modeling-centered calculus for assessing health risks in part because a united front of corporate and corporate-consultant scientists harped on the uncertainties of newer findings. The article concludes that the agency needs to rethink its risk assessment practices and dependence, as well as more effectively account for financial conflicts of interest in evaluations of policy-relevant science. (Am J Public Health. 2025;115(7):1074-1084. https://doi.org/10.2105/AJPH.2025.308073).
More Related Videos
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Drug Regulation

